These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 32639233)

  • 21. Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.
    Gevers S; Kwa MSG; Wijnans E; van Nieuwkoop C
    Clin Microbiol Infect; 2020 Sep; 26(9):1276-1277. PubMed ID: 32422406
    [No Abstract]   [Full Text] [Related]  

  • 22. Chloroquine and hydroxychloroquine repositioning in times of COVID-19 pandemics, all that glitters is not gold.
    Paumgartten FJR; Delgado IF; Pitta LDR; Oliveira ACAX
    Cad Saude Publica; 2020; 36(5):e00088520. PubMed ID: 32428074
    [No Abstract]   [Full Text] [Related]  

  • 23. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties.
    Smit C; Peeters MYM; van den Anker JN; Knibbe CAJ
    Clin Pharmacokinet; 2020 Jun; 59(6):659-669. PubMed ID: 32306288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.
    Yazdany J; Kim AHJ
    Ann Intern Med; 2020 Jun; 172(11):754-755. PubMed ID: 32232419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review.
    Jankelson L; Karam G; Becker ML; Chinitz LA; Tsai MC
    Heart Rhythm; 2020 Sep; 17(9):1472-1479. PubMed ID: 32438018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Disease (COVID-19).
    Keshtkar-Jahromi M; Bavari S
    Am J Trop Med Hyg; 2020 May; 102(5):932-933. PubMed ID: 32247318
    [No Abstract]   [Full Text] [Related]  

  • 28. Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings.
    Abena PM; Decloedt EH; Bottieau E; Suleman F; Adejumo P; Sam-Agudu NA; Muyembe TamFum JJ; Seydi M; Eholie SP; Mills EJ; Kallay O; Zumla A; Nachega JB
    Am J Trop Med Hyg; 2020 Jun; 102(6):1184-1188. PubMed ID: 32323646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals.
    Mallhi TH; Ahmad A; Butt MH; Misbah S; Khan YH; Alotaibi NH
    J Coll Physicians Surg Pak; 2020 Oct; 30(10):124-128. PubMed ID: 33115586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management.
    Lebin JA; LeSaint KT
    West J Emerg Med; 2020 Jun; 21(4):760-763. PubMed ID: 32726238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: a critical appraisal.
    Khuroo MS
    Int J Antimicrob Agents; 2020 Sep; 56(3):106101. PubMed ID: 32687949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose.
    Doyno C; Sobieraj DM; Baker WL
    Clin Toxicol (Phila); 2021 Jan; 59(1):12-23. PubMed ID: 32960100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).
    Gao J; Hu S
    Biosci Trends; 2020 May; 14(2):156-158. PubMed ID: 32281583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence.
    Roustit M; Guilhaumou R; Molimard M; Drici MD; Laporte S; Montastruc JL;
    Therapie; 2020; 75(4):363-370. PubMed ID: 32473812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help.
    Lentini G; Cavalluzzi MM; Habtemariam S
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32316270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Position statement from the Brazilian Society of Nephrology regarding chloroquine and hydroxychloroquine drug dose adjustment according to renal function.
    Moura-Neto JA; Misael AM; Silva DRD; D'Avila R; Andreoli MCC; Kraychete A; Bastos K; Nascimento MMD
    J Bras Nefrol; 2020 Aug; 42(2 suppl 1):49-50. PubMed ID: 32877501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19.
    Lei ZN; Wu ZX; Dong S; Yang DH; Zhang L; Ke Z; Zou C; Chen ZS
    Pharmacol Ther; 2020 Dec; 216():107672. PubMed ID: 32910933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits.
    Halm MA
    Am J Crit Care; 2020 Nov; 29(6):489-492. PubMed ID: 32839815
    [No Abstract]   [Full Text] [Related]  

  • 39. COVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients?
    Javelot H; El-Hage W; Meyer G; Becker G; Michel B; Hingray C
    Br J Clin Pharmacol; 2020 Jun; 86(6):1176-1177. PubMed ID: 32350872
    [No Abstract]   [Full Text] [Related]  

  • 40. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.